期刊文献+

含骨形态发生蛋白2骨修复材料在颈椎前路减压植骨融合中的应用 被引量:6

Application of bone repair materials containing recombinant human bone morphogenetic protein-2 in anterior cervical discectomy and fusion
下载PDF
导出
摘要 背景:颈椎前路椎间盘切除减压自体髂骨植骨融合是治疗颈椎病的标准术式,但取自体髂骨存在较多供骨区并发症,寻找合适的骨修复替代材料应用于颈椎前路手术一直是研究的热点。目的:分析含骨形态发生蛋白2骨修复材料在颈椎前路减压融合中的临床效果。方法:回顾性分析行颈前路减压植骨融合治疗40例患者的临床资料,其中试验组21例将含骨形态发生蛋白2的骨修复材料(载体为药用明胶、注射用大豆卵磷脂、羟基磷灰石等)及自体骨赘植入PEEK cage融合器,对照组19例将自体骼骨植入PEEK cage融合器。随访12个月,比较两组融合节段Cobb角、融合节段椎体前缘高度、椎间高度、并发症、融合率、JOA评分和目测类比评分等指标。结果与结论:经过治疗后,两组均获得了即刻的颈椎稳定,颈椎前凸、融合节段椎体前缘高度及椎间高度均较治疗前明显增加(P<0.05)。随访12个月时,试验组Cobb角明显大于对照组(P<0.05),两组融合节段椎间隙前缘高度与融合节段椎间高度、椎间融合率、颈部与上肢目测类比评分、JOA评分比较差异无显著性意义,均获得骨性愈合。表明含骨形态发生蛋白2的骨修复材料结合自体骨赘植骨应用于颈椎前路减压融合可有效恢复并维持颈椎前凸、融合节段的高度,在改善临床症状方面与自体髂骨疗效相当。 The anterior cervical discectomy and fusion with autologous bone is the standard surgical treatment for cervical spondylosis, but there are more complications occurring during the harvesting of autologous iliac bone. To find suitable alternative materials used in bone repair surgery has been a research focus. OBJECTIVE:To analyze the clinical and radiographic outcomes in patients undergoing anterior cervical discectomy with fusion using polyetheretherketone cages packed with bone repair material containing recombinant human bone morphogenetic protein-2. METHODS:A total of 40 consecutive patients with cervical spinal degenerative disease who underwent anterior cervical discectomy and fusion were enrol ed. We retrospectively reviewed anterior cervical discectomy with fusion using polyetheretherketone cages packed with bone repair material containing recombinant human bone morphogenetic protein-2 and autologous osteophyte in 21 cases and with autologous iliac crest in 19 cases. These patients had sequential radiographs before and after surgery, and at 1 year. The anterior disc height, interbody height, segmental Cobb angle, complication, and fusion rate were assessed based on radiographs including flexion/extension radiographs and CT scan. The neurologic outcomes were evaluated using the visual&amp;nbsp;analog scale score for neck and arm pain and the Japanese Orthopedic Association scoring system for myelopathy. RESULTS AND CONCLUSION:At the last fol ow-up, solid fusion appeared to have been achieved in patients of both groups. Lordosis was increased significantly in both groups after surgery (P〈0.05), and was maintained up until 1 year without a difference between groups. Both the anterior disc height and interbody height were significantly increased after surgery (P〈0.05), without a significant difference between groups. At the last fol ow-up, the Cobb angle in the test group was significantly higher than that in the control group (P〈0.05), but there was no significant difference i
出处 《中国组织工程研究》 CAS CSCD 2014年第43期6889-6895,共7页 Chinese Journal of Tissue Engineering Research
关键词 骨形态发生蛋白质类 颈椎 脊柱融合术 bone morphogenetic proteins cervical vertebrae spinal fusion
  • 相关文献

参考文献27

  • 1Smith GW, Robinson RA.The treatment of certain cervical- spine disorders by anterior removal of the intervertebral disc and interbody fusion. J Bone Joint Surg Am.1958;40-A(3):607-624. 被引量:1
  • 2Cahill KS,Chi JH,DayA,et aI.Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009;302(1 ): 58-66. 被引量:1
  • 3Smucker JD,Rhee JM,Singh K,et al.lncreased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.Spine (Phila Pa 1976).2006;31 (24): 2813-2819. 被引量:1
  • 4Buttermann GR.Prospective nonrandomized comparison of an allograt: with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J.2008;8(3):426-435. 被引量:1
  • 5Vaidya R,Carp J,Sethi A, et aI.CompUcations of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.Eur Spine J.2007;16(8): 1257-1265. 被引量:1
  • 6Poynton AR,Lane JM.Safety profile for the clinical use of bone morphogenetic proteins in the spine.Spine (Phila Pa 1976). 2002;27(16 Suppl 1):S40-48. 被引量:1
  • 7McKay B,Sandhu HS.Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine (Phila Pa 1976).2002;27(16 Suppl 1 ):S66-85. 被引量:1
  • 8Anderson DW, Burton DC,Jackson RS.Postoperative cervical myelopathy and cord compression associated with the use of recombinant bone morphogenetic protein-2 in posterior cervical decompression, instrumentation, and arthrodesis: a report of two cases.Spine (Phila Pa 1976).2011 ;36(10): E682-686. 被引量:1
  • 9Haid RW Jr, Branch CL Jr, Alexander JT, et al.Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.Spine J.2004;4(5):527-538. 被引量:1
  • 10Vaccaro AR,Carrino JA,Venger BH,et al.Use of a bioabsorbable anterior cervical plate in the treatment of cervical degenerative and traumatic disc disruption. J Neurosurg.2002;97(4 Suppl):473-480. 被引量:1

同被引文献53

  • 1.中医病证诊断疗效标准[S].[S].国家中医药管理局,1994.124. 被引量:77
  • 2Izumida S, Inoue S. Assessment of treatment for low back pain [Jl" J Jpn Orthop Assoc, 1986, 60: 391. 被引量:1
  • 3Azimi P, Mohammadi H R, Montazeri A. An outcome measure of functionality and pain in patients with lumbar disc herniation: a validation study of the Japanese Orthopedic Association (JOA) score[J]. J Orthop Sci, 2012, 17: 341. 被引量:1
  • 4Brantigan J W, Stefee A D, Lewis M L, et al. Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pediele screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial[J]. Spine (Phila Pa 1976), 2000, 25 (11): 1437. 被引量:1
  • 5Chin D K, Park J Y, Yoon Y S, et al. Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease[J]. Osteoporos Int, 2007, 18 (9): 1219. 被引量:1
  • 6Kalb S, Perez-Orribo L, Kalani M Y, et al. The influence of common medical conditions on the outcome of anterior lumbar interbody fusion[J/OLJ. J Spinal Disord Tech, 2013. [Epub ahead of print] . 被引量:1
  • 7Frenkel M B, Cahill K S, Javahary R J, et al. Fusion rates in multilevel, instrumented anterior cervical fusion for degenerative disease with and without the use of bone morphogenetic protein [J]. J Neurosurg Spine, 2013, 18 (3): 269. 被引量:1
  • 8SMITH Z A, BUCHANAN C C, RAPHAEL D, et al. Ossification of the posterior longitudinal ligament: patho-genesis, management, and current surgical approaches. A review[J]. Neurosurg Focus, 2011, 30(3) : El0. 被引量:1
  • 9MASAKI Y, YAMAZAKI M, OKAWA A, et al. An a- nalysis of factors causing poor surgical outcome in patients With cervical myelopathy due to ossification of the posteri- or longitudinal ligament: anterior decompression with spi- nal fusion versus laminoplasty [ J ]. J Spinal Disord Tech, 2007, 20 ( 1 ) : 7 - 13. 被引量:1
  • 10SE1CHI A, CHIKUDA H, K1MURA A, et al. Intraoper- ative uhra-sonographic evaluation of posterior decompres- sion via laminoplasty in patients with cervical ossification of the posterior longitudinal ligament: correlation with 2- year follow-up results[ J]. J Neurosurg Spine, 2010, 13 (1) :47 -51. 被引量:1

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部